A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...

Chinese, other Asian, Middle Eastern, Black African or African-Caribbean ethnic backgrounds, NICE said. It was found to be cost effective after data from the SURMOUNT-1 study reported that after 72 ...

Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit these popular categories the hardest.

Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ...

Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, but growth may accelerate after 2026. Read more here.

Evaluate’s latest analysis forecasts an $82 billion increase in major product revenues in 2025 – the largest annual growth ...

These launches are positioned for multi-blockbuster status, thanks to their promise of fulfilling unmet needs, impacting ...

Outside China, the tirzepatide products are known as Mounjaro ... that its placebo-controlled DREAMs-1 trial of mazdutide in Chinese adults with type 2 diabetes inadequately controlled by diet ...

The company faced significant disruptions last year due to shortages of tirzepatide ... which would limit US funding of Chinese biotechnology suppliers, has yet to pass. The WuXi representative ...

The company’s recent success with its incretin portfolio, including tirzepatide and orforglipron ... particularly the potential for a Chinese invasion of Taiwan, which could lead to a global ...

There are two drugs on the market - semaglutide, marketed under the brand name Wegovy, and tirzepatide ... severely obese range Those with an Asian, Chinese, Middle Eastern, Black African or ...